Clinical trial to test promising new treatment for chronic cough
The National Institute for Health Research (NIHR) is to participate in a clinical trial to test a promising new treatment for chronic cough.
If approved, AF-219 would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist.
Click on this link for more information.
